A detailed history of Oberweis Asset Management Inc transactions in Veracyte, Inc. stock. As of the latest transaction made, Oberweis Asset Management Inc holds 715,920 shares of VCYT stock, worth $30.7 Million. This represents 1.31% of its overall portfolio holdings.

Number of Shares
715,920
Previous 654,100 9.45%
Holding current value
$30.7 Million
Previous $14.2 Million 71.88%
% of portfolio
1.31%
Previous 0.9%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$21.0 - $35.25 $1.3 Million - $2.18 Million
61,820 Added 9.45%
715,920 $24.4 Million
Q2 2024

Aug 14, 2024

SELL
$18.86 - $23.55 $331,936 - $414,480
-17,600 Reduced 2.62%
654,100 $14.2 Million
Q1 2024

May 15, 2024

BUY
$21.0 - $29.1 $312,690 - $433,299
14,890 Added 2.27%
671,700 $14.9 Million
Q4 2023

Feb 14, 2024

BUY
$19.72 - $28.68 $1.17 Million - $1.7 Million
59,270 Added 9.92%
656,810 $18.1 Million
Q3 2023

Nov 14, 2023

BUY
$22.33 - $29.92 $2.57 Million - $3.45 Million
115,230 Added 23.89%
597,540 $13.3 Million
Q2 2023

Aug 14, 2023

BUY
$20.96 - $26.99 $5.66 Million - $7.29 Million
270,130 Added 127.31%
482,310 $12.3 Million
Q1 2023

May 15, 2023

BUY
$20.58 - $27.89 $2.47 Million - $3.34 Million
119,780 Added 129.63%
212,180 $4.73 Million
Q4 2022

Feb 14, 2023

BUY
$15.31 - $29.94 $1.41 Million - $2.77 Million
92,400 New
92,400 $2.19 Million
Q4 2019

Feb 14, 2020

SELL
$20.78 - $29.99 $467,550 - $674,775
-22,500 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$23.87 - $30.93 $150,381 - $194,859
-6,300 Reduced 21.88%
22,500 $540,000
Q2 2019

Aug 14, 2019

SELL
$22.1 - $28.56 $236,470 - $305,592
-10,700 Reduced 27.09%
28,800 $821,000
Q1 2019

May 15, 2019

SELL
$12.0 - $25.76 $956,400 - $2.05 Million
-79,700 Reduced 66.86%
39,500 $988,000
Q4 2018

Feb 14, 2019

BUY
$9.15 - $14.85 $290,055 - $470,745
31,700 Added 36.23%
119,200 $1.5 Million
Q3 2018

Nov 14, 2018

BUY
$9.55 - $12.64 $835,625 - $1.11 Million
87,500 New
87,500 $836,000

Others Institutions Holding VCYT

About VERACYTE, INC.


  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $3.07B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track Oberweis Asset Management Inc Portfolio

Follow Oberweis Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oberweis Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oberweis Asset Management Inc with notifications on news.